MULLEN JAMES C

Average Profitability
3.63%
Insider Buys Quantity
3
Insider Buys Sum
$1.71M
Insider Sells Quantity
56
Insider Sells Sum
$116.89M

Insider Activity of MULLEN JAMES C

The largest purchase of all time was on 2021-03-02 and amounted to 25000 shares of Editas Medicine, Inc. for $1.16M.

The largest sale of all time was on 2008-04-11 and amounted to 745750 shares of Biogen Inc. for $48.29M.

Biography of MULLEN JAMES C

No biography is available at this moment.

2022-01-03SaleEditas Medicine, Inc.
EDIT
CEO
18,252
0.026%
$26.95$491,979-47.34%
2021-10-18SaleEditas Medicine, Inc.
EDIT
CEO
13,805
0.0201%
$38.03$525,033-57.33%
2021-03-02PurchaseEditas Medicine, Inc.
EDIT
CEO
25,000
0.0384%
$46.27$1.16M-17.22%
2018-05-18PurchaseEditas Medicine, Inc.
EDIT
director
10,000
0.0232%
$38.03$380,252-20.34%
2017-11-13PurchaseInsulet Corporation
PODD
director
2,500
0.0042%
$67.45$168,633+26.04%
2010-03-22SaleBiogen Inc.
BIIB
CEO & President
106,279
0.0395%
$59.95$6.37M-3.61%
2010-03-19SaleBiogen Inc.
BIIB
CEO & President
334,221
0.1245%
$59.97$20.04M-3.36%
2009-12-16SaleBiogen Inc.
BIIB
CEO & President
147,037
0.0544%
$50.18$7.38M+10.12%
2008-04-15SaleBiogen Inc.
BIIB
CEO & President
12,800
0.003%
$44.59$570,752-22.49%
2008-04-14SaleBiogen Inc.
BIIB
CEO & President
200
<0.0001%
$44.59$8,918-21.01%
2008-04-11SaleBiogen Inc.
BIIB
CEO & President
745,750
0.259%
$64.75$48.29M-21.64%
2006-11-27SaleBiogen Inc.
BIIB
CEO & President
12,500
0.0026%
$36.09$451,125+0.96%
2006-11-20SaleBiogen Inc.
BIIB
CEO & President
159,000
0.0468%
$51.11$8.13M+0.47%
2006-11-17SaleBiogen Inc.
BIIB
CEO & President
70,123
0.0204%
$49.95$3.5M+1.41%
2006-11-16SaleBiogen Inc.
BIIB
CEO & President
220,565
0.0592%
$45.40$10.01M+3.1%
2006-04-28SaleBiogen Inc.
BIIB
CEO & President
8,675
0.0026%
$45.25$392,559+1.98%
2005-01-24SaleBiogen Inc.
BIIB
CEO & President
5,500
0.0016%
$63.22$347,716-37.33%
2005-01-18SaleBiogen Inc.
BIIB
CEO & President
5,500
0.0016%
$67.78$372,770-41.77%
2005-01-10SaleBiogen Inc.
BIIB
CEO & President
5,500
0.0016%
$66.52$365,857-40.92%
2005-01-03SaleBiogen Inc.
BIIB
CEO & President
5,500
0.0017%
$67.67$372,163-40.44%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.